HCW Biologics Inc. (HCWB)

NASDAQ: HCWB · Real-Time Price · USD

8.70

-0.48 (-5.23%)

At close: May 21, 2025, 4:00 PM

8.50

-0.20 (-2.30%)

After-hours: May 21, 2025, 4:15 PM EDT

HCW Biologics Employees

HCW Biologics had 36 employees as of December 31, 2024. The number of employees decreased by 9 or -20.00% compared to the previous year.

Employees

36

Change (1Y)

-9

Growth (1Y)

-20.00%

Revenue / Employee

$40,143

Profits / Employee

-$687,573

Market Cap

9.74M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	36	-9	-20.00%
Dec 31, 2023	45	1	2.27%
Dec 31, 2022	44	0	-
Dec 31, 2021	44	4	10.00%
Dec 31, 2020	40	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Abbott Laboratories	114,000
AstraZeneca	94,300
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000
AbbVie	55,000

Employee Rankings

HCWB News

5 days ago - HCW Biologics Reports First Quarter 2025 Business Highlights and Financial Results - GlobeNewsWire
7 days ago - HCW Biologics Announces Pricing of $5.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules - GlobeNewsWire
8 days ago - HCW Biologics Announces Positive Results of Studies of Proprietary Compound, HCW9206 and Availability for Commercialization - GlobeNewsWire
7 weeks ago - HCW Biologics Announces 1-for-40 Reverse Stock Split - GlobeNewsWire
7 weeks ago - HCW Biologics Reports Fourth Quarter and Fiscal Year 2024 Business Highlights and Financial Results - GlobeNewsWire
2 months ago - HCW Biologics Granted Extension by the Nasdaq Hearings Panel to Regain Compliance with Continued Listing Requirements - GlobeNewsWire
3 months ago - HCW Biologics Granted FDA Clearance to Evaluate One of the Company's Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial - GlobeNewsWire
4 months ago - HCW Biologics' Founder and CEO to Address Opportunities and Challenges in Biomanufacturing for Cell and Gene Therapies During J.P. Morgan Week in San Francisco on January 15, 2025 - GlobeNewsWire